Schaetzl, T., Modest, D. P., Stintzing, S., Müller, L., Graeven, U., Weikersthal, L. F. V., Kasper, S., Goekkurt, E., Reinacher-Schick, A. C., Caca, K., Alig, A. H. S., Kurreck, A., Hoppe, B., Meyer-Knees, J. W., Lang, T. J. L., Horst, D., Jarosch, A., Heinemann, V., Trarbach, T., Stahler, A. (2026). Prognostic and predictive value of baseline derived neutrophil-to-lymphocyte ratio (dNLR) in
                    <i>RAS</i>
                    wild-type (WT) metastatic colorectal cancer (mCRC) receiving 5-fluorouracil and folinic acid (FU/FA) with or without panitumumab (Pmab) maintenance: A post-hoc analysis of the PANAMA/AIO KRK 0212) trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15552